Abstract
Active artificial bone composed of poly lactide-co-glycolide (PLGA)/ tricalcium phosphate (TCP) was prefabricated using low-temperature rapid-prototyping technology so that the process of osteogenesis could be observed in it. PLGA and TCP were the primary materials, they were molded at low temperature, then recombinant human bone morphogenetic protein-2 (rhBMP-2) was added to form an active artificial bone. Goats with standard cranial defects were randomly divided into experimental (implants with rhBMP-2 added) and control (implants without rhBMP-2) groups, and osteogenesis was observed and evaluated by imaging and biomechanical and histological examinations. The PLGA-TCP artificial bone scaffold (90% porosity) had large and small pores of approximately 360microm and 3-5microm diameter. Preliminary and complete repair of the cranial defect in the goats occurred 12 and 24 weeks after surgery, respectively. The three-point bending strength of the repaired defects attained that of the normal cranium. In conclusion, low-temperature rapid-prototyping technology can preserve the biological activity of this scaffold material. The scaffold has a good three-dimensional structure and it becomes an active artificial bone after loading with rhBMP-2 with a modest degradation rate and excellent osteogenesis in the goat.
MeSH terms
-
Animals
-
Biocompatible Materials / chemistry
-
Biocompatible Materials / therapeutic use*
-
Biomedical Engineering
-
Bone Diseases / pathology
-
Bone Diseases / surgery*
-
Bone Morphogenetic Protein 2
-
Bone Morphogenetic Proteins / therapeutic use*
-
Bone Regeneration / physiology*
-
Bone Substitutes / chemistry
-
Bone Substitutes / therapeutic use*
-
Calcium Phosphates / chemistry
-
Calcium Phosphates / therapeutic use*
-
Cold Temperature
-
Disease Models, Animal
-
Female
-
Goats
-
Guided Tissue Regeneration / methods
-
Humans
-
Imaging, Three-Dimensional
-
Lactic Acid / chemistry
-
Lactic Acid / therapeutic use*
-
Male
-
Microscopy, Electron, Scanning
-
Osteogenesis / physiology
-
Pliability
-
Polyglycolic Acid / chemistry
-
Polyglycolic Acid / therapeutic use*
-
Polylactic Acid-Polyglycolic Acid Copolymer
-
Porosity
-
Random Allocation
-
Recombinant Proteins / therapeutic use*
-
Skull / pathology
-
Skull / surgery*
-
Stress, Mechanical
-
Surface Properties
-
Time Factors
-
Tissue Scaffolds*
-
Tomography, X-Ray Computed
-
Transforming Growth Factor beta / therapeutic use*
Substances
-
Biocompatible Materials
-
Bone Morphogenetic Protein 2
-
Bone Morphogenetic Proteins
-
Bone Substitutes
-
Calcium Phosphates
-
Recombinant Proteins
-
Transforming Growth Factor beta
-
recombinant human bone morphogenetic protein-2
-
Polylactic Acid-Polyglycolic Acid Copolymer
-
Polyglycolic Acid
-
Lactic Acid
-
tricalcium phosphate